Log in to save to my catalogue

The additional radiotherapy to adjuvant chemotherapy improves the prognosis of stage III-N2 with hig...

The additional radiotherapy to adjuvant chemotherapy improves the prognosis of stage III-N2 with hig...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3153551178

The additional radiotherapy to adjuvant chemotherapy improves the prognosis of stage III-N2 with highest mediastinal lymph node metastasis in non-small cell lung cancer

About this item

Full title

The additional radiotherapy to adjuvant chemotherapy improves the prognosis of stage III-N2 with highest mediastinal lymph node metastasis in non-small cell lung cancer

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

Journal of cancer research and clinical oncology, 2023-11, Vol.149 (14), p.13311-13321

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

Scope and Contents

Contents

Introduction
The benefits of adjuvant chemoradiation therapy (CRT) for heterogeneous pathological N2 (pN2) diseases remain unclear in non-small cell lung cancer (NSCLC). This study aimed to investigate suitable pN2 patients for adjuvant CRT.
Material and methods
This study retrospectively reviewed the data of patients with pN2 NSCLC in Sha...

Alternative Titles

Full title

The additional radiotherapy to adjuvant chemotherapy improves the prognosis of stage III-N2 with highest mediastinal lymph node metastasis in non-small cell lung cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_3153551178

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3153551178

Other Identifiers

ISSN

0171-5216

E-ISSN

1432-1335

DOI

10.1007/s00432-023-05101-6

How to access this item